DW Healthcare Partners Invests in Vets Plus and Noble Pharma

DW Healthcare Partners Invests in Parnell Pharmaceuticals

February 1, 2021

Veterinary

DW Healthcare Partners completed an investment in Parnell Pharmaceuticals Holdings Ltd, a fully integrated animal-health pharmaceutical developer and sterile-injectable manufacturer, and took seats on the company's board. DWHP said the capital and board expansion will support Parnell's growth in the U.S. and expansion of its product portfolio and manufacturing capabilities in animal health.

Veterinary Pharmaceutical Solutions Acquires Diamond Animal Health

January 18, 2024

Veterinary

Veterinary Pharmaceutical Solutions (VPS), a Granite Creek Capital Partners portfolio company, acquired Diamond Animal Health from Mars Corporation. Granite Creek supported the deal with a follow-on investment from its FlexCap II fund, creating an integrated animal health platform combining VPS's compounding capabilities with Diamond's contract manufacturing and vaccine production.

DW Healthcare Partners Invests in Bio Agri Mix

July 27, 2021

Veterinary

DW Healthcare Partners completed an investment in Bio Agri Mix LP, Canada’s largest manufacturer and distributor of medicated feed additives and water-soluble animal medications. As part of the transaction DWHP partners join Bio Agri Mix’s board and will support expansion of the company’s product portfolio and growth across the North American livestock market.

Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners

August 30, 2022

Veterinary

Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.

Whistler Capital Partners Makes Strategic Growth Investment in Heart + Paw

January 3, 2024

Healthcare Services

Whistler Capital Partners, a Nashville-based healthcare-focused private equity firm, has made a significant strategic growth investment in Heart + Paw, a multi-service veterinary and pet care platform. The capital will support Heart + Paw’s de novo expansion, technology and operations investments, and its veterinarian joint-venture model; financial terms were not disclosed.

EQT to Acquire VetPartners from National Veterinary Associates

October 11, 2023

Veterinary

EQT has agreed to acquire VetPartners, the largest provider of veterinary and animal health services in Australia and New Zealand, from National Veterinary Associates. VetPartners operates a network of 267 clinics and specialty hospitals with over 4,300 clinical and support staff; EQT says it will invest in diagnostic equipment, technology, recruitment and training to support continued growth and improved clinical outcomes. The transaction is subject to customary approvals and is expected to close around the end of the calendar year.